Form 4 Tracker
Blake Borgeson

Director · 8 filings · Latest: Aug 4, 2026

RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Borgeson BlakeSep 17, 2024
Proposed Sale
$6.8411,447$78.3K
RXRX
Borgeson BlakeSep 3, 2024
Proposed Sale
$6.2711,447$71.7K

← Previous

Page 2 of 2